EverHeart Systems Now Corvion, Inc.

EverHeart Systems, developer of fully implanted mechanical circulatory support devices, announced today that it has changed its corporate name to Corvion, Inc. The name change has been chosen to further differentiate the Company’s products and mission from others in the mechanical circulatory assist device field and better reflects the company’s focus on high efficiency and wireless solutions for patients needing cardiac support.

Everheart Systems Now Corvion, Inc.

“The new corporate name Corvion, Inc. – allows us to emphasize our world class pump efficiency and robust wireless charging technology that we believe will drive a new era in the use Left Ventricular Assist Devices (LVADs).  Patients will no longer be tethered to their controller and batteries, which limits their quality of life in so many ways. Decades have gone by with no viable fully implanted LVAD. We think it’s time for a radical change,” commented Greg S. Aber, CEO of Corvion, Inc.

The new name is effective immediately and will be implemented across the company’s products and presentations throughout next year.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”